Blog
Breach and attack simulation vs CTEM: where they overlap
Breach and attack simulation tools run attacker techniques against your environment on a schedule and tell you whether your controls caught them. CTEM’s validation stage runs exploitation attempts against your environment and tells you whether a specific exposure is exploitable. Said that fast, they sound like the same product with a different label. They are not, and the gap between them is exactly where a lot of “CTEM platform” marketing lives.
What BAS actually tests
A BAS tool ships with a library of attacker techniques, usually mapped to MITRE ATT&CK, and executes them against your environment on a schedule: a credential dumping technique, a lateral movement technique, a known ransomware behaviour, a specific C2 communication pattern. It then checks what happened. Did the EDR agent flag it. Did the SIEM rule fire. Did the email gateway block the payload. Did the proxy stop the callback.
The unit under test is the control, not the target. BAS does not care whether the specific host it ran the simulation on has a real, exploitable path to anything valuable. It cares whether the technique, as a known and catalogued pattern, gets caught. Run the same simulation against two hosts with identical EDR coverage and you expect the same result on both, because the question is “does this control class work,” not “is this asset exposed.”
That makes BAS good at a narrow and useful thing: catching control drift. A detection rule that worked in January can silently stop working after an agent update, a SIEM tuning pass, or a policy change nobody tied back to security coverage. Running the ATT&CK-mapped library continuously is how you find that out before an attacker does, rather than during an incident retrospective.
What CTEM validation actually tests
CTEM’s validation stage starts somewhere different: with a specific exposure that discovery and prioritisation already found in your actual environment. An over-privileged service account on a particular host. A misconfigured storage bucket. A vulnerable service version on a system that sits on a path to the finance database. Validation asks one question about that one thing: can an attacker actually use it, from here, to reach what we said we cared about.
The method looks like a scoped, safe penetration test rather than a technique library. It chains the specific exposure into whatever it actually leads to in your environment: this account plus this trust relationship plus this network path equals a route to the domain controller, or it doesn’t. The output is not “technique T1078 was detected” but “this exposure, on this host, is exploitable, and here is what it reaches” or “this exposure looks bad on paper and isn’t, because the path is blocked by a control we didn’t know was in the way.”
The difference is what each result generalises to. A BAS result about a technique generalises across your environment, because the control either catches that technique class or it doesn’t. A validation result about an exposure generalises to nothing else; it is a fact about one specific finding.
| Question | BAS | CTEM validation |
|---|---|---|
| Unit under test | A control (EDR, SIEM rule, gateway) | A specific discovered exposure |
| Source of the test case | ATT&CK-mapped technique library | Discovery and prioritisation output |
| Result | Detected / blocked / missed | Exploitable / not exploitable, and what it reaches |
| Cadence | Continuous, scheduled | Per exposure, on the prioritised list |
| Answers | “Would our controls catch this technique class?” | “Is this exposure, right now, a real path to something that matters?” |
Why BAS is a good input, not a substitute
None of that makes BAS useless to a CTEM program — the opposite. A validation team that already knows a control gap exists, because BAS flagged it, can prioritise exposures that route through that gap higher than ones a working control would likely stop. Gartner’s own framing folds BAS into a broader category it calls adversarial exposure validation, alongside automated penetration testing and automated red teaming, precisely because they are complementary ways of producing evidence that an attack is feasible (Gartner, March 2025 Market Guide for Adversarial Exposure Validation). BAS output is one of the better feeds into the validation stage’s evidence, particularly for the “would this be detected if it happened” half of the question.
What it cannot do is stand in for the cycle. Scoping is a conversation with business owners about which processes and assets matter; a technique library has no opinion on that. Discovery is finding the exposures that exist in your specific environment; BAS does not enumerate your asset inventory, your forgotten subdomains, or your over-permissioned identities — it runs a fixed library against whatever you already pointed it at. Mobilisation is a named owner, a ticket, and a verified close; BAS produces a report on control coverage, not a remediation workflow with an owner attached. A BAS deployment, run perfectly, tells you a great deal about your detection posture and nothing about whether last month’s exposure list actually mattered or got fixed.
When a BAS vendor calls itself a CTEM platform
Some BAS vendors now market their product as a full CTEM platform, and it is worth being specific about what is usually missing when they do. Scoping is almost never there; the product has no workflow for agreeing which business processes are in play, because it was not built to talk to business owners. Discovery is thin to absent; a technique library is not an asset inventory, and running simulations against hosts you already know about does not find the ones you don’t. Prioritisation exists only in the narrow sense of ranking which detection gaps to fix first, not in the sense of ranking exposures by business impact, because the tool was never shown your exposures in the first place. Mobilisation is usually a report or a set of suggested detection rules, not a tracked remediation pipeline with ownership and verified closure.
What is genuinely there, and genuinely valuable, is a strong, continuous answer to one part of validation: control efficacy against known techniques. That is worth buying. It is worth buying as a validation input, priced and evaluated as one stage of a five-stage cycle, not as the cycle itself. The tell is usually in the sales deck: if scoping and mobilisation get a slide each and discovery gets a mention, but validation-by-technique gets the whole demo, you are looking at a very good BAS tool wearing a CTEM label.
Next
Read CTEM tools: what each category actually does for how BAS compares to automated penetration testing and the rest of the validation toolkit, CTEM vs vulnerability management for why validation exists as a stage at all, and use the vendor directory to check what a specific BAS product actually covers before you buy it as a platform.